Clinical Study
Different Effects of Myoinositol plus Folic Acid versus Combined Oral Treatment on Androgen Levels in PCOS Women
Table 1
Comparison of demographic and clinical characteristics of group 1 and group 2.
| | GROUP 1-COC () | GROUP 2-MYO () | |
| Age (years) | | | 0.061 | Gravida | | | 0.962 | Parity | | | 0.536 | BMI (kg/m2) | | | 0.098 | WHR | | | 0.064 | Mean artery pressure (mmHg) | | | 0.020 | Ferriman Gallwey score | | | 0.116 | Right ovary volume (cm3) | | | 0.545 | Left ovary volume (cm3) | | | 0.495 | Total ovary volume (cm3) | | | 0.486 | Right ovary antral follicle count | | | 0.458 | Left ovary antral follicle count | | | 0.449 | Total antral follicle count | | | 0.399 |
|
|
COC: combined oral contraceptives, MYO: myoinositol + folic acid, BMI: body mass index, and WHR: waist hip ratio. Independent -test.
|